Phase 4, School-based, Open-labeled Research Trial for Control of Epidemic Influenza Through a School-based Influenza Vaccination Program in Central Texas.
Phase of Trial: Phase IV
Latest Information Update: 23 May 2017
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms CEI
- 16 May 2017 Status changed from active, no longer recruiting to completed.
- 16 Mar 2010 Official title amended and trial sponsors (Novartis and Sanofi Pasteur MSD) added as reported by ClinicalTrials.gov record.
- 16 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.